Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 1
2013 1
2014 1
2017 1
2019 2
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Significance of EGFR Expression in Circulating Tumor Cells.
Serrano MJ, Alvarez-Cubero MJ, De Miguel Pérez D, Rodríguez-Martínez A, Gonzalez-Herrera L, Robles-Fernandez I, Hernandez JE, Puche JLG, Lorente JA. Serrano MJ, et al. Among authors: puche jlg. Adv Exp Med Biol. 2017;994:285-296. doi: 10.1007/978-3-319-55947-6_16. Adv Exp Med Biol. 2017. PMID: 28560681 Review.
Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective.
Molina-Zayas M, Garrido-Navas C, García-Puche JL, Barwell J, Pedrinaci S, Atienza MM, García-Linares S, de Haro-Muñoz T, Lorente JA, Serrano MJ, Poyatos-Andújar A. Molina-Zayas M, et al. Among authors: garcia puche jl. Mol Genet Genomics. 2022 May;297(3):859-871. doi: 10.1007/s00438-022-01891-5. Epub 2022 Apr 22. Mol Genet Genomics. 2022. PMID: 35451682 Free PMC article.
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients.
de Miguel Pérez D, Rodriguez Martínez A, Ortigosa Palomo A, Delgado Ureña M, Garcia Puche JL, Robles Remacho A, Exposito Hernandez J, Lorente Acosta JA, Ortega Sánchez FG, Serrano MJ. de Miguel Pérez D, et al. Among authors: garcia puche jl. Sci Rep. 2020 Mar 4;10(1):3974. doi: 10.1038/s41598-020-60212-1. Sci Rep. 2020. PMID: 32132553 Free PMC article.
Biomarkers characterization of circulating tumour cells in breast cancer patients.
Nadal R, Fernandez A, Sanchez-Rovira P, Salido M, Rodríguez M, García-Puche JL, Macià M, Corominas JM, Delgado-Rodriguez M, Gonzalez L, Albanell J, Fernández M, Solé F, Lorente JA, Serrano MJ. Nadal R, et al. Among authors: garcia puche jl. Breast Cancer Res. 2012 May 3;14(3):R71. doi: 10.1186/bcr3180. Breast Cancer Res. 2012. PMID: 22554015 Free PMC article.
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, Ilyine H, Lorente JA, Legueren M, Serrano MJ. Rodríguez-Martínez A, et al. Among authors: garcia puche jl. Breast Cancer Res. 2019 Feb 6;21(1):21. doi: 10.1186/s13058-019-1109-0. Breast Cancer Res. 2019. PMID: 30728048 Free PMC article.
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM; GEICAM 9906 Study Investigators. Martín M, et al. Among authors: garcia puche jl. J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27. J Natl Cancer Inst. 2008. PMID: 18505968 Free article. Clinical Trial.
Plasmacytoid lymphoma treated with rituximab as first-line monotherapy.
Blancas I, Zarcos I, Gómez FJ, Delgado MT, Carrillo J, Legerén M, Ríos B, Pacios E, Jurado JM, Sánchez MJ, Fonseca R, García Puche JL. Blancas I, et al. Among authors: garcia puche jl. Clin Transl Oncol. 2009 Oct;11(10):704-6. doi: 10.1007/s12094-009-0429-4. Clin Transl Oncol. 2009. PMID: 19828416 No abstract available.